NewcelX Ltd.
- Market Cap (Float-Adj) (Float-adjusted market cap computed by the low-float screener — matches the screener row. May differ from the standard cap (price × all shares outstanding) reported elsewhere.)
- $18.7M
- Price
- $3.26
- % Change (Daily % change from the live per-ticker quote feed.)
- -3.18%
- Volume
- 1.4K
About
NewcelX Ltd., a biotechnology company, engages in developing transformative cell-based and small-molecule therapies for neurodegenerative and metabolic diseases. The company was founded in 2008 and is headquartered in Zurich, Switzerland.
Quick stats
Shares outstanding5.7M
Computed float2.4M
Float / shares42.1%
Key info
SectorHealthcare
IndustryBiotechnology
CIK (Central Index Key — the unique ID the SEC assigns to every filer. Use it to look up the company's filings on EDGAR.)0001783036
Websitehttps://www.newcelx.com
AI Summary
AI-generated1/12
standardbullishoffering
NewcelX Announces Pricing of $1.4 Million Equity Financing at 20% Premium Pricing
NewcelX priced a $1.4 million private placement at $4.033 per share, a 20% premium to the July 30 closing price, alongside warrants exercisable at $4.437.
The offering includes participation from existing shareholders and is expected to close on or about August 14, 2026.
Net proceeds will be used primarily to advance the lead type 1 diabetes program NCEL-101 in collaboration with Eledon Pharmaceuticals and for working capital.